Optimization of EGFR mutation detection by the fully-automated qPCR-based Idylla system on tumor tissue from patients with non-small cell lung cancer

Treatment with EGFR inhibitors is limited to patients with advanced/metastatic non-small cell lung cancer who have known EGFR mutations. Currently, patient care has to respond to several imperatives to make these inhibitors broadly available to all patients; fast and accurate detection of EGFR mutat...

Descripción completa

Detalles Bibliográficos
Autores principales: Ilie, Marius, Butori, Catherine, Lassalle, Sandra, Heeke, Simon, Piton, Nicolas, Sabourin, Jean-Christophe, Tanga, Virginie, Washetine, Kevin, Long-Mira, Elodie, Maitre, Priscilla, Yazbeck, Nathalie, Bordone, Olivier, Lespinet, Virginie, Leroy, Sylvie, Cohen, Charlotte, Mouroux, Jérôme, Marquette, Charles Hugo, Hofman, Véronique, Hofman, Paul
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5732710/
https://www.ncbi.nlm.nih.gov/pubmed/29262544
http://dx.doi.org/10.18632/oncotarget.21476

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5732710/
https://www.ncbi.nlm.nih.gov/pubmed/29262544
http://dx.doi.org/10.18632/oncotarget.21476

Ejemplares similares